The people making a difference
The company employs a highly educated staff with years of experience in DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization, and clinical manufacturing.
As such our facilities in USA and The Netherlands, are well-positioned to take on any challenge associated with the development of complex biological medicines be it proteins, antibodies, vaccines or viral vectors.
Batavia Biosciences was founded in 2010 by Chris Yallop and Menzo Havenga. Chris build his career first on recombinant proteins and antibodies, while Menzo did the same on vaccines and viral vectors.
During their career, they experienced both the benefits and hurdles associated with outsourcing. Using that experience, they decided to build their own contract development and manufacturing organization, positioned to help clients from an early idea through process development into clinical GMP manufacturing.
Menzo Havenga and Chris Yallop founded, what was then still called, Batavia Bioservices. With a staff of 7 dedicated people, vaccine and therapeutic protein projects for the first customers were…
The acquisition gave Batavia access to simulated moving bed purification technology as well as infrastructure, and microbial process and product development. With the acquisition the company had doubled its staff.
Batavia Bioservices Inc. launches laboratory infrastructure in the Greater Boston area. 10,000 ft2 of dedicated BSL-2 laboratories are fully equipped to accommodate the increasing market demand from the US.
In 2014 the company opened an office in Hong Kong to serve the growing order portfolio in Asia.
Guides Towards Excellence.
The management team of our CDMO brings together decades of experience in the pharmaceutical and biotech industries, providing the expertise necessary to successfully navigate the complex drug development process.
Dr. Christopher Yallop
Chief Operations Officer
Dr. Menzo Havenga
President & CEO
Dr. Ron van Eijsden
Chief Business Officer
Head of Operations
Pablo Mendes de León
Chief Financial Officer